Science Explorer Back to mapMap

Most cited papers from Onassis Cardiac Surgery Center

What are the most cited papers from Onassis Cardiac Surgery Center?

The most cited paper from Onassis Cardiac Surgery Center is "Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease" (Cardiogenics et al., 2011), with 1,959 citations. Next come "Large-scale association analysis identifies new risk loci for coronary artery disease" (1,681) and "Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology" (889).

Showing 50 of 60 papers. Every paper with more than 210 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Cardiogenics et al. · Nature Genetics Open access167 authors 6 Mar 2011 1,959
2 Large-scale association analysis identifies new risk loci for coronary artery disease Panos Deloukas et al. · Nature Genetics Open access183 authors 2 Dec 2012 1,681
3 Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology María G. Crespo‐Leiro et al. · European Journal of Heart Failure Open access 28 May 2018 889
4 Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization Matthew T. Roe et al. · New England Journal of Medicine Open access 26 Aug 2012 884
5 Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine Børge Grønne Nordestgaard et al. · European Heart Journal Open access 26 Apr 2016 864
6 Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study Roxana Mehran et al. · The Lancet Sep 2013 620
7 Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review Konstantinos E. Farsalinos, Riccardo Polosa · Therapeutic Advances in Drug Safety ReviewOpen access 13 Feb 2014 615
8 Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery Massimo Francesco Piepoli, Ugo Corrà, Stamatis N. Adamopoulos et al. · European Journal of Preventive Cardiology Open access 20 Jun 2012 604
9 Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria Domenico Corrado et al. · International Journal of Cardiology Open access 16 Jun 2020 586
10 Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study Emmanuel Ekanem et al. · Nature Medicine Open access139 authors Jul 2024 484
11 Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human Kobra Haghighi, Fotis Kolokathis, Luke E. Pater et al. · Journal of Clinical Investigation Open access 15 Mar 2003 463
12 Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits Joshua C. Randall et al. · PLoS Genetics Open access265 authors 6 Jun 2013 462
13 The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals Georg Ehret et al. · Nature Genetics Open access313 authors 12 Sep 2016 446
14 Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non–Small Cell Lung Cancer by Quantitative Real-Time RT-PCR Athina N. Markou, Emily G. Tsaroucha, Loukas Kaklamanis et al. · Clinical Chemistry Open access 21 Aug 2008 442
15 Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices Konstantinos E. Farsalinos, Alketa Spyrou, Kalliroi Tsimopoulou et al. · Scientific Reports Open access 26 Feb 2014 440
16 Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe Nikolaos Dagres, Robby Nieuwlaat, PANOS E. VARDAS et al. · Journal of the American College of Cardiology Open access 23 Jan 2007 438
17 Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study Seisyou Kou et al. · European Heart Journal - Cardiovascular Imaging Open access 21 Jan 2014 435
18 COVID-19 Home Confinement Negatively Impacts Social Participation and Life Satisfaction: A Worldwide Multicenter Study Achraf Ammar et al. · International Journal of Environmental Research and Public Health Open access 27 Aug 2020 422
19 Characteristics, Perceived Side Effects and Benefits of Electronic Cigarette Use: A Worldwide Survey of More than 19,000 Consumers Konstantinos E. Farsalinos, Giorgio Romagna, Dimitris Tsiapras et al. · International Journal of Environmental Research and Public Health Open access 22 Apr 2014 387
20 Effects of home confinement on mental health and lifestyle behaviours during the COVID-19 outbreak: Insight from the ECLB-COVID19 multicenter study Achraf Ammar et al. · Biology of Sport Open access 26 Aug 2020 385
21 Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: A prospective randomized study* Mariantina Fragou, Andreas I. Gravvanis, Vasilios Dimitriou et al. · Critical Care Medicine 25 Mar 2011 379
22 Genetic evidence of assortative mating in humans Matthew R. Robinson et al. · Nature Human Behaviour 533 authors 9 Jan 2017 371
23 A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy Kobra Haghighi, Fotis Kolokathis, Anthony O. Gramolini et al. · Proceedings of the National Academy of Sciences Open access 23 Jan 2006 371
24 Physical training reduces peripheral markers of inflammation in patients with chronic heart failure Stamatis N. Adamopoulos · European Heart Journal May 2001 370
25 Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis Domenico Corrado et al. · European Heart Journal Open access 5 Sep 2019 367
26 Low serum albumin: A neglected predictor in patients with cardiovascular disease Antonis S. Manolis, Antonis S. Manolis, Theodora A. Manolis et al. · European Journal of Internal Medicine 7 May 2022 362
27 Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study Roberta Manganaro et al. · European Heart Journal - Cardiovascular Imaging Open access 7 Nov 2018 353
28 The present and future of deep learning in radiology Luca Saba, Mainak Biswas, Venkatanareshbabu Kuppili et al. · European Journal of Radiology 2 Mar 2019 352
29 Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study Tadafumi Sugimoto et al. · European Heart Journal - Cardiovascular Imaging 2 May 2017 351
30 Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation Stavroula N. Psychari, Thomas S Apostolou, Loukas Sinos et al. · The American Journal of Cardiology Mar 2005 323
31 Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins Konstantinos E. Farsalinos, Kurt A. Kistler, I. Gene Gillman et al. · Nicotine & Tobacco Research Open access Sep 2014 312
32 The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox Dimitrios Moris, Michael Spartalis, Eleftherios D Spartalis et al. · Annals of Translational Medicine Open access Aug 2017 310
33 Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR (Part II) Luc Vanhees, Nickos D. Geladas, Dominique Hansen et al. · European Journal of Preventive Cardiology Open access 30 Nov 2011 308
34 Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement Genovefa D. Kolovou, Dimitri P. Mikhailidis, Jan Kovar et al. · Current Vascular Pharmacology 25 Apr 2011 306
35 Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC) Mauro Pepi, Arturo Evangelista, Petros Nihoyannopoulos et al. · European Journal of Echocardiography Open access Jul 2010 298
36 Psychological consequences of COVID-19 home confinement: The ECLB-COVID19 multicenter study Achraf Ammar et al. · PLoS ONE Open access 5 Nov 2020 295
37 Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial Pieter Cornelis Smits, Sjoerd H. Hofma, Mario Togni et al. · The Lancet 30 Jan 2013 293
38 Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ Regulation Konstantinos E. Farsalinos, Giorgio Romagna, Dimitris Tsiapras et al. · International Journal of Environmental Research and Public Health Open access 18 Jun 2013 273
39 Patient Profiling in Heart Failure for Tailoring Medical Therapy. A Consensus Document of the Heart Failure Association of the European Society of Cardiology Giuseppe M.C. Rosano et al. · European Journal of Heart Failure Open access May 2021 270
40 Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure Stamatis N. Adamopoulos, John Parissis, Dimitrios Karatzas et al. · Journal of the American College of Cardiology Open access Feb 2002 270
41 The continuous heart failure spectrum: moving beyond an ejection fraction classification Filippos K. Triposkiadis et al. · European Heart Journal Open access 8 Mar 2019 267
42 Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM Michel R. Langlois et al. · Clinical Chemistry Open access 14 May 2018 263
43 Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study Tadafumi Sugimoto et al. · European Heart Journal - Cardiovascular Imaging Open access 18 Jan 2018 263
44 Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids) Gabrielle Norrish et al. · JAMA Cardiology Open access 15 Aug 2019 259
45 Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study Larissa Gussatschenko Caballero et al. · European Heart Journal - Cardiovascular Imaging Open access 20 Apr 2015 259
46 Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates Jan Janoušek, Roman Gebauer, Hashim Abdul‐Khaliq et al. · Heart Open access 22 Mar 2009 257
47 The Prevalence of Metabolic Syndrome in Various Populations Genovefa D. Kolovou, Katherine K. Anagnostopoulou, Klelia D. Salpea et al. · The American Journal of the Medical Sciences Jun 2007 249
48 Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation Anna Ringborg, Robby Nieuwlaat, Peter Lindgren et al. · EP Europace Open access 7 Mar 2008 241
49 Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM Børge Grønne Nordestgaard et al. · Atherosclerosis Open access 9 Jan 2020 240
50 Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis Vasileios Kouranos, George E. Tzelepis, Aggeliki Rapti et al. · JACC. Cardiovascular imaging Open access 15 Mar 2017 239

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.